Cipla, Guojian launch first biosimilar Enbrel in India

Cipla has launched the first cut-price etanercept, a biosimilar version of Amgen's Enbrel, in India under an alliance with Shanghai CP Guojian Pharmaceutical, marking the Indian generic company's much anticipated entry into the biologics space.